A Prospective Research Investigation of Ischemia Using MCG

Description

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Conditions

Acute Coronary Syndrome

Talk to us

Study Overview

On this page

Study Details

Study overview

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device

A Prospective Research Investigation of Ischemia Using MCG

Condition
Acute Coronary Syndrome
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
  • * Ability for participant to comply with study requirements
  • * Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
  • * Written informed consent
  • * Present STEMI
  • * Pregnant or breastfeeding
  • * Having an active atrial fibrillation episode as seen on most current 12-lead ECG
  • * Active thoracic metal implant
  • * Poor access to follow-up

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

SB Technology, Inc.,

Kit Yee Au-Yeung, PhD, STUDY_DIRECTOR, SB Technology, Inc.

Study Record Dates

2025-06